XL-765
- Voxtalisib - SAR245409
- Soluble in DMSO
- MF: C13H14N6O
- MW: 270.29
Description
XL765, a pyridopyrimidinone-derivative, is a highly selective, potent and reversible ATP-competitive inhibitor of pan-Class I PI3K (α, β, γ, and δ) and mTORC1/mTORC2. It is orally active, highly selective over 130 other protein kinases. In cellular assays, XL765 inhibits the formation of PIP3 in the membrane, and inhibits phosphorylation of AKT, p70S6K, and S6 phosphorylation in multiple tumor cell lines with different genetic alterations affecting the PI3K pathway. In mouse xenograft models, oral administration of XL-765 results in dose-dependent inhibition of phosphorylation of AKT, p70S6K, and S6 with a duration of action of approximately 24 hours. Repeat dose administration of XL765 results in significant tumor growth inhibition in multiple human xenograft models in nude mice that is associated with antiproliferative, antiangiogenic, and proapoptotic effects.
More Information
| Parent CAS No. | 934493-76-2 |
|---|---|
| Chemical Name | 2-Amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7(8H)-one |
| extra_info | Sold in collaboration with Chemietek |
| SMILES | N1C(C)=C2C=C(C3NN=CC=3)C(=O)N(CC)C2=NC=1N |
| MFCD | N.A. |
| InChi | InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17) |
| InChiKey | RGHYDLZMTYDBDT-UHFFFAOYSA-N |
| CID | 16123056 |
| Short Description | PI3K (α, β, γ, δ) and mTORC1/mTORC2 inhibitor |
References
- P Yu et al. Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway. Mol Cancer Ther. 2014 May;13(5):1078-91.
- KP Papadopoulos et al. Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245409 (XL765), a novel, orally administered PI3K/mTOR inhibitor in patients with advanced solid tumors. Clin Cancer Res. 2014 May 1;20(9):2445-56.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 3792 | PITCOIN3 |
From Inquiry |
| 4075 | Serabelisib |
From Inquiry |
| 4133 | IPI-145 |
From Inquiry |
| 4149 | Everolimus |
From Inquiry |
| 4172 | PITCOIN4 |
From $242.00 |
